This is consistent with the aforementioned phenomenon that BRCA1-associated human breast tumors have significantly increased chance of carrying TP53 mutations, compared to BRCA1-unrelated breast tumors [7,64]. This evidence concerns the gene TP53 and breast neoplasm.